WallStreetZenWallStreetZen

NASDAQ: TLSI
Trisalus Life Sciences Inc Stock Ownership - Who owns Trisalus Life Sciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Trisalus Life Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James Emmett YoungChief Financial Officer2025-02-056,000$5.65
$33.90kBuy
Mary T. SzelaCEO AND PRESIDENT2025-01-305,010$5.28
$26.45kBuy
Mary T. SzelaCEO AND PRESIDENT2025-01-295,030$5.03
$25.30kBuy
Sean MurphyChief Manuf StrategyBus Dev.2025-01-2815,000$5.17
$77.55kBuy
Mary T. SzelaCEO AND PRESIDENT2025-01-284,716$5.12
$24.15kBuy
Mary T. SzelaCEO AND PRESIDENT2025-01-274,826$5.42
$26.16kBuy
Sean MurphyChief Manuf StrategyBus Dev.2025-01-2715,000$5.31
$79.65kBuy
James Emmett YoungChief Financial Officer2025-01-2724,000$5.40
$129.60kBuy
Mats WahlstromDirector2024-12-1725,188$3.97
$100.00kBuy
Equity Ab Frankenius10% Owner2024-12-1762,972$3.97
$250.00kBuy

1 of 2

TLSI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TLSI insiders and whales buy or sell their stock.

TLSI Shareholders

What type of owners hold Trisalus Life Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Medtech Acquisition Sponsor LLC20.50%6,249,999$32.87MInsider
Equity Ab Frankenius20.43%6,230,748$32.77MInsider
Mats Wahlstrom8.74%2,665,202$14.02MInsider
Kerry R. Hicks7.51%2,289,199$12.04MInsider
David J. Matlin3.09%941,944$4.95MInsider
Wealthcare Advisory Partners LLC2.11%643,740$3.39MInstitution
Sean Murphy2.08%634,372$3.34MInsider
Vanguard Group Inc1.56%476,292$2.51MInstitution
Mary T. Szela1.53%465,348$2.45MInsider
Duquesne Family Office LLC1.40%426,921$2.25MInstitution

1 of 3

TLSI vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TLSI8.09%67.55%Net BuyingNet Buying
BDMD1.21%24.53%
BWAY17.72%0.00%
PROF55.85%0.00%
CATX28.06%71.94%Net Buying
View Top Medical Device Stocks

Trisalus Life Sciences Stock Ownership FAQ

Who owns Trisalus Life Sciences?

Trisalus Life Sciences (NASDAQ: TLSI) is owned by 8.09% institutional shareholders, 67.55% Trisalus Life Sciences insiders, and 24.37% retail investors. Medtech Acquisition Sponsor LLC is the largest individual Trisalus Life Sciences shareholder, owning 6.25M shares representing 20.50% of the company. Medtech Acquisition Sponsor LLC's Trisalus Life Sciences shares are currently valued at $32.87M.

If you're new to stock investing, here's how to buy Trisalus Life Sciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.